Optimizing Investments in Belarus for the National HIV Response
This report summarizes the findings of an allocative efficiency analysis on Belarus` national HIV epidemic and response conducted in 2014-15. The report addresses core questions for resource allocation such "How can HIV funding be optimally al...
Main Author: | |
---|---|
Other Authors: | |
Format: | Report |
Language: | English en_US |
Published: |
World Bank, Washington, DC
2016
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/154881477990805232/Optimizing-investments-in-Belarus-for-the-national-HIV-response http://hdl.handle.net/10986/25395 |
Summary: | This report summarizes the findings of
an allocative efficiency analysis on Belarus` national HIV
epidemic and response conducted in 2014-15. The report
addresses core questions for resource allocation such
"How can HIV funding be optimally allocated to the
combination of HIV response interventions that will yield
the highest impact?" or "What level of investment
is required to achieve national targets, if we allocate
resources optimally?". The report describes
epidemiological and HIV financing trends as well as
identifies sub-populations, which are most affected by the
epidemic. Based on this information, the optimized mix of
interventions for minimizing new HIV infections and deaths
is identified using mathematical modelling techniques.
Belarus could increase the impact of its HIV program by
reallocating funds to high-impact programs. It could enhance
this impact by increasing the total funding available to the
HIV response so that high-impact programs could be scaled up
further. With optimized allocations of the same amount of
funding available as in 2013 (US$19.7 million), over
2015–20, new HIV infections could be reduced by 7 percent
and deaths by 25 percent. Doubling the investment in
high-impact programs would require 148 percent of total 2013
spending (US$29.5 million). Compared to 2013 allocations,
over 2015–20, the 148 percent investment would achieve a
remarkable reduction in new infections by 43 percent and in
deaths by 51 percent. |
---|